We provide 1 form of Tranexamic acid
Tranexamic acid
1197-18-8
|
157.11
|
-1.801
Tranexamic acid is an antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. Tranexamic acid competitively and reversibly inhibits the activation of plasminogen via binding at several distinct sites, including four or five low-affinity sites and one high-affinity site, the latter of which is involved in its binding to fibrin.
Tranexamic acid | trans-4-aminomethyl-cyclohexyl-carboxylic acid
Tranexamic acid is an antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. Tranexamic acid competitively and reversibly inhibits the activation of plasminogen via binding at several distinct sites, including four or five low-affinity sites and one high-affinity site, the latter of which is involved in its binding to fibrin.
Tranexamic acid | trans-4-aminomethyl-cyclohexyl-carboxylic acid
$19/5 mg
(EBC)
1
We provide 3 compounds for Tranexamic acid
Tranexamic acid impurity D CRS
4-(aminomethyl)benzoic acid
4-(Aminomethyl)benzoic acid
56-91-7
151.063
-1.433
$19/5 mg
(EBC)
1
Tranexamic acid impurity C CRS
4-(aminomethyl)cyclohex-1-ene-1-carboxylic acid
Tranexamic EP Impurity C
330838-52-3
155.095
-1.785
$138/5 mg
(EBC)
1
Tranexamic Acid Related Compound C
4-(aminomethyl)cyclohex-1-ene-1-carboxylic acid hydrochloride
-
1803601-44-6
191.071
-1.785
$120/5 mg
(EBC)
1